Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT07187479 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease (Stages 4 and 5)
Kidney Disease
Type 2 Diabetes

Interventions

OTHER: Physiologic Insulin Resensitization (PIR)

Sponsor

Well Cell Global